REFERENCES
- Bukstein, O. (2009) Substance use disorders and attention deficit hyperactivity disorder. CNS Spectrum, 14(7) (Suppl. 6), 10–12.
- Konstenius, M., Jayaram-Lindstrom, N., Beck, O., Franck, J. (2010). Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study. Drug and Alcohol Dependence, 108, 130–133. doi: 10.1016/j.drugalcdep.2009.11.006.
- National Institute on Drug Abuse. (2005, August). Medications development research for treatment of amphetamine and methamphetamine addiction: Report to Congress. Retrieved February 7, 2012 from http://archives.drugabuse.gov/pdf/methmeds.pdf.
- National Institute on Drug Abuse, (2011, March). InfoFacts: Treatment statistics. Retrieved from http://www.drugabuse.gov/publications/infofacts/treatment-statistics.
- National Institute on Drug Abuse. (2011, May). InfoFacts: Drug-related hospital emergency room visits. Retrieved February 7, 2012 from http://www.drugabuse.gov/publications/infofacts/drug-related-hospital-emergency-room-visits.
- Schindler, C. W., Gilman, J. P., Panlilio, L. V., McCann, D. J., & Goldberg, S. R. (2011). Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys. Experimental and ClinicalPsychopharmacology, 19(1), 1–10. doi: 10.1037/a0022432.
- Stahl, S. M. (2008). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications. 3rd edition. New York, NY: Cambridge University Press.
- Zhu, J., Spencer, T. J., Liu-Chen, L.-Y., Biederman, J., & Bhide, P. G. (2011). Methylphenidate and μ opioid receptor interactions: A pharmacological target for prevention of stimulant abuse. Neuropharmacology, 61, 283–292. doi: 10.1016/j.neuropharm.2011.04.015.
- Zorick, T., Mandelkern, M. A., Lee, B., Wong, M.-L., Miotto, K., Shahbazian, J., & London, E. D. (2011). Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. The American Journal of Drug and Alcohol Abuse, 37, 62–67. doi: 10.3109/00952990.2010.538945.